OTC Drug Manufacturer Perrigo Recalling Some Acetominophen Caplets

Company said it found traces of metal in some caplets.

Perrigo, a large manufacturer of over-the-counter pharmaceutical and nutritional products for the store brand market, said Thursday it is voluntarily recalling some of its store-brand Acetaminophen 500 mg caplets on a nationwide basis because of trace amounts of metal in some of the caplets.

"Although the frequency of occurrence is very low, the probability of health risk is remote, and there have been no reports of injuries or illness related to this incident, we are taking this measure to maintain the highest possible product quality standards for our retail customers and their store brand consumers," said John Hendrickson, EVP and General Manager of Perrigo Consumer Healthcare.

Perrigo is informing distributors and retailers about the recall, which affects 383 batches, and has outlined steps it will take to facilitate product replacement. Questions or concerns about the product should be directed to Perrigo's Consumer Affairs Department, toll free, 877-546-0454. Any adverse reactions experienced with the use of this product should also be reported to the FDA MedWatch Program by phone at 800-FDA-1088, by fax at 800-FDA-0178 or on the MedWatch website at http://www.fda.gov/medwatch.

The total cost of the recall for sales returns, handling of on-hand inventories and disposal is estimated to be $2.9 million, and discussions are on-going with the raw material supplier to determine the extent to which the recall-related costs may be recoverable.